GGrantIndex
Sort

78,016 grants matching breast cancer

Premenopausal Hormone Levels and Risk of Breast Cancer

$820,256
Susan E. Hankinson · Harvard School Of Public Health · R01 · FY2006 · CA

Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance

$820,178
Robert David Schreiber · Washington University · U01 · FY2010 · CA

Cancer Center Support Grant

$820,000
Steven D Leach · Dartmouth College · P30 · FY2020 · CA

Reporting Adult-Onset Genomic Results to Pediatric Biobank Participants and Parents

$819,711
Adam H Buchanan · Geisinger Clinic · R01 · FY2018 · HG

Community Networks Program: The Johns Hopkins Center to Reduce Cancer Disparities

$819,591
Jean G. Ford · Johns Hopkins University · U54 · FY2011 · CA

Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer

$819,590
Louise C Showe · Wistar Institute · U01 · FY2019 · CA

Northwest Community Clinical Oncology Program

$819,526
Tacoma General Hospital · U10 · FY2003 · CA

Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor

$819,364
Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Minority Based Community Clinical Oncology Program

$819,197
David J Peace · University Of Illinois At Chicago · U10 · FY2009 · CA

Molecular, Cellular, and Tissue Characterization Unit

$819,068
Joe W. Gray · Oregon Health & Science University · U2C · FY2018 · CA

INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY

$818,987
Riverside Research Institute · R01 · FY2001 · CA

MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM

$818,903
Mount Sinai Medical Center (Miami Beach) · U10 · FY2004 · CA

GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management

$818,820
Guilherme Del Fiol · University Of Utah · U24 · FY2023 · CA

Time Domian Electron Paramagnetic Resonance Imaging

$817,876
Murali Cherukuri · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Increasing Engagement in Patient Reported Outcome Measurement to Address Breast Cancer Care Disparities using Health Information Technology in Community Cancer Settings

$817,746
Maria Orlando Edelen · Brigham And Women'S Hospital · R01 · FY2023 · CA

TGF-betas in breast cancer progression

$817,677
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Development of TGF-beta antagonists for cancer therapy

$817,677
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Mechanobiology

$817,653
Alexander Cartagena-Rivera · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2021 · EB

Alliance for Clinical Trials in Oncology Operations Center - GY9 NCCAPS Additional Capitation

$817,650
Steven Piantadosi · Brigham And Women'S Hospital · U10 · FY2023 · CA

The Worcester Venous Thromboembolism Study

$817,624
Frederick A Spencer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2008 · HL

Engineering Multifunctional Nanoparticles

$817,618
Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2008 · CA

Germline and Tumor Genomic Analyses of Breast Cancer in Latinas

$817,565
Susan L. Neuhausen · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA

Development of TGF-beta antagonists for cancer therapy

$817,474
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

TGF-betas in breast cancer progression

$817,474
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells

$817,442
Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA